MedPath

GLYCOPYRROLATE 1ML

Glycopyrrolate Injection

Approved
Approval ID

1bb2fa8a-3318-1e9a-2c79-8371bcae3d1c

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 23, 2023

Manufacturers
FDA

XIROMED LLC

DUNS: 080228637

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Glycopyrrolate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code70700-264
Application NumberANDA212227
Product Classification
M
Marketing Category
C73584
G
Generic Name
Glycopyrrolate
Product Specifications
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS
Effective DateMarch 19, 2019
FDA Product Classification

INGREDIENTS (5)

GLYCOPYRROLATEActive
Quantity: 0.2 mg in 1 mL
Code: V92SO9WP2I
Classification: ACTIB
WATERInactive
Code: 059QF0KO0R
Classification: IACT
BENZYL ALCOHOLInactive
Quantity: 9 mg in 1 mL
Code: LKG8494WBH
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

GLYCOPYRROLATE 1ML - FDA Drug Approval Details